The SGLT2 Inhibitor Dapagliflozin Disrupts the Cell Cycle at High Concentrations Without Altering Glycosphingolipid (De Novo)Biosynthesis. - Jennemann, Richard; Sandhoff, Roger (International Journal of Molecular Sciences, 2025)